nach oben

Erschienen in:

01.06.2013 | Original Paper

Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy

verfasst von: Lasse K. Bak, Helle S. Waagepetersen, Michael Sørensen, Peter Ott, Hendrik Vilstrup, Susanne Keiding, Arne Schousboe

Erschienen in: Metabolic Brain Disease | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Hepatic encephalopathy (HE) is associated with increased ammonia levels in plasma and brain. Different treatment strategies have been developed to ameliorate the detrimental effects of the ammonia load. One such strategy is based on the finding of a low level of the branched chain amino acids (BCAAs) in plasma of patients suffering from HE and the assumption that in particular isoleucine could be beneficial to brain energy metabolism as it is metabolized to the tricarboxylic acid cycle intermediate and precursor succinyl-CoA and acetyl-CoA, respectively. This would enable de novo synthesis of glutamine via α-ketoglutarate and glutamate and at the same time stimulate oxidative metabolism. The present mini-review summarizes the metabolic basis for this hypothesis delineating studies in the brain in vivo as well as in cultured neural cells aimed at elucidating the metabolism of the BCAAs focusing on isoleucine. The conclusion is that isoleucine appears at least partially to act in this fashion albeit its metabolism is quantitatively relatively modest. In addition, a short section on the role of the BCAAs in synaptic ammonia homeostasis is included along with some thoughts on the role of the BCAAs in other pathologies such as cancer.

Abrahams SL, Younathan ES (1971) Modulation of the kinetic properties of phosphofructokinase by ammonium ions. J Biol Chem 246(8):2464–2467PubMed

Amaral AI, Teixeira AP, Martens S, Bernal V, Sousa MF, Alves PM (2010) Metabolic alterations induced by ischemia in primary cultures of astrocytes: merging 13C NMR spectroscopy and metabolic flux analysis. J Neurochem 113(3):735–748PubMedCrossRef

Bak LK, Schousboe A, Waagepetersen HS (2006) The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 98:641–653PubMedCrossRef

Bak LK, Johansen ML, Schousboe A, Waagepetersen HS (2007) Among the branched-chain amino acids only valine metabolism is up-regulated in astrocytes during glutamate exposure. J Neurosci Res 86:3465–3470CrossRef

Bak LK, Iversen P, Sørensen M, Keiding S, Vilstrup H, Ott P, Waagepetersen HS, Schousboe A (2009) Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia. Metab Brain Dis 24:135–145PubMedCrossRef

Berl S, Frigyesi TL (1968) Metabolism of [14C]leucine and [14C]acetate in sensorimotor cortex, thalamus, caudate nucleus and cerebellum of the cat. J Neurochem 15(9):965–970PubMedCrossRef

Berl S, Frigyesi TL (1969) Comparison of cerebral regional metabolism of [14C]leucine following third ventricle and intravenous administration in the cat. J Neurochem 16(3):405–415PubMedCrossRef

Cole JT, Mitala CM, Kundu S, Verma A, Elkind JA, Nissim I, Cohen AS (2010) Dietarybranched chain amino acids ameliorate injury-induced cognitive impairment. Proc Natl Acad Sci U S A 107(1):366–371PubMedCrossRef

Cooper AJ (2011) ¹³ N as a tracer for studying glutamate metabolism. Neurochem Int 59(4):456–464PubMedCrossRef

Dadsetan S, Bak LK, Sørensen M, Keiding S, Vilstrup H, Ott P, Leke R, Schousboe A, Waagepetersen HS (2011) Inhibition of glutamine synthetase induces glutamate dehydrogenase-dependent ammonia fixation into alanine in co-cultures of astrocytes and neurons. Neurochem Int 59:482–488PubMedCrossRef

Dadsetan S, Sørensen M, Bak LK, Vilstrup H, Ott P, Schousboe A, Jalan R, Keiding S, Waagepetersen HS (2013) Interorgan metabolism of ornithine phenylacetate—A novel strategy for treatment of hyperammonimia. Biochem Pharmacol 85:115–123

Dam G, Keiding S, Ol M, Ott P, Buhl M, Vilstrup H, Bak LK, Waagepetersen HS, Schousboe A, Møller N, Sørensen M (2011) Branched-chain amino acids increase arterial blood ammonia in spite of enhanced intrinsic ammonia metabolism in patients with cirrhosis and healthy subjects. Am J Gastrointest Liver Physiol 301:G269–G277CrossRef

Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, Deindoerfer F (1974) Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am J Surg 127(1):40–47PubMedCrossRef

Gjedde A, Lockwood AH, Duffy TE, Plum F (1978) Cerebral blood flow and metabolism in chronically hyperammonemic rats: effect of an acute ammonia challenge. Ann Neurol 3:325–330PubMedCrossRef

Hertz L, Yu ACH, Kala G, Schousboe A (2000) Neuronal-astrocytic and cytosolic-mitochondrial metabolite trafficking during brain activation, hyperammonemia and energy deprivation. Neurochem Int 37:83–102PubMedCrossRef

Hindfelt B, Plum F, Duffy TE (1977) Effect of acute ammonia intoxication on cerebral metabolism in rats with portacaval shunts. J Clin Invest 59:386–396PubMedCrossRef

Hutson SM, Islam MM, Zaganas I (2011) Interaction between glutamate dehydrogenase (GDH) and L-leucine catabolic enzymes: intersecting metabolic pathways. Neurochem Int 59(4):518–524PubMedCrossRef

Islam MM, Nautiyal M, Wynn RM, Mobley JA, Chuang DT, Hutson SM (2010) Branched-chain amino acid metabolon: interaction of glutamate dehydrogenase with the mitochondrial branched-chain aminotransferase (BCATm). J Biol Chem 285(1):265–276PubMedCrossRef

Islam MM, Wallin R, Wynn RM, Conway M, Fujii H, Mobley JA, Chuang DT, Hutson SM (2007) A novel branched-chain amino acid metabolon. Protein-protein interactions in a supramolecular complex. J Biol Chem 282(16):11893–11903PubMedCrossRef

Jalan R, Wright G, Davies NV, Hodges SJ (2007) L-Ornithine phenylacetate (OP): a novel treatment for hyperammonemia and hepatic encephalopathy. Med Hypotheses 69:1064–1069PubMedCrossRef

Johansen ML, Bak LK, Schousboe A, Iversen P, Sørensen M, Keiding S, Vilstrup H, Gjedde A, Ott P, Waagepetersen HS (2007) The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes. Neurochem Int 50:1042–1051PubMedCrossRef

Kala G, Hertz L (2005) Ammonia effects on pyruvate/lactate production in astrocytes-Interaction with glutamate. Neurochem Int 47:4–12PubMedCrossRef

Laj JC, Cooper AJ (1986) Brain alpha-ketogkutarate dehydrogenase complex: kinetic properties, regional distribution, and effects of inhibitors. J Neurochem 47:1376–1386CrossRef

Leke R, Bak LK, Anker M, Melø TM, Sørensen M, Keiding S, Vilstrup H, Ott P, Portela LV, Sonnewald U, Schousboe A, Waagepetersen HS (2011) Detoxification of ammonia in mouse cortical GABAergic cell cultures increases neuronal oxidative metabolism and reveals an emerging role for release of glucose-derived alanine. Neurotox Res 19:496–510PubMedCrossRef

Lieth E, LaNoue KF, Berkich DA, Xu B, Ratz M, Taylor C, Hutson SM (2001) Nitrogen shuttling between neurons and glial cells during glutamate synthesis. J Neurochem 76:1712–1723PubMedCrossRef

McKhann GM, Tower DB (1961) Ammonia toxicity and cerebral oxidative metabolism. Am J Physiol 200:420–424PubMed

Müting D, Wortmann V (1956) Über den aminosäurenhaushalt bei leberkrankheiten. Deutsche Medizinische Wochenschrift 45:1853–1856CrossRef

Obel LF, Andersen KMH, Bak LK, Schousboe A, Waagepetersen HS (2012) Effects of adrenergic agents on intracellular Ca²⁺ homeostasis and metabolism of glucose in astrocytes with emphasis on pyruvate carboxylation, oxidative decarboxylation and recycling: Implications for glutamate neurotransmission and excitotoxicity. Neurotox Res 21:405–417PubMedCrossRef

Olde Damink SW, Deutz NE, Dejong CH, Soeters PB, Jalan R (2002) Interorgan ammonia metabolism in liver failure. Neurochem Int 41(2–3):177–188PubMedCrossRef

Ott P, Clemmesen O, Larsen FS (2005) Cerebral metabolic disturbances in the brain during acute liver failure: From hyperammonemia to energy failure and proteolysis. Neurochem Int 47:13–18PubMedCrossRef

Sheen JH, Zoncu R, Kim D, Sabatini DM (2011) Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 19(5):613–628PubMedCrossRef

Yu ACH, Schousboe A, Hertz L (1984) Influence of pathological concentrations of ammonia on metabolic fate of ¹⁴C-labeled glutamate in astrocytes in primary cultures. J Neurochem 42:594–597PubMedCrossRef

Yudkoff M (1997) Brain metabolism of branched-chain amino acids. Glia 21(1):92–98PubMedCrossRef

Zwingmann C, Richter-Landsberg C, Brand A, Leibfritz D (2000) NMR spectroscopic study on the metabolic fate of [¹³C]alanine in astrocytes, neurons, and cocultures. Implications for neuron-glia interactions in neurotransmitter metabolism. Glia 32:386–303CrossRef

Zwingmann C, Chatauret N, Leibfritz D, Butterworth RF (2003) Selective increase of brain lactate synthesis in experimental acute liver failure. Results of a [H-C] nuclear magnetic resonance study. Hepatology 37:420–428PubMedCrossRef

Waagepetersen HS, Sonnewald U, Larsson OM, Schousboe A (2000) A possible role of alanine for ammonia transfer between astrocytes and glutamatergic neurons. J Neurochem 75(2):471–9

Titel: Role of branched chain amino acids in cerebral ammonia homeostasis related to hepatic encephalopathy
verfasst von: Lasse K. Bak
Helle S. Waagepetersen
Michael Sørensen
Peter Ott
Hendrik Vilstrup
Susanne Keiding
Arne Schousboe
Publikationsdatum: 01.06.2013
Verlag: Springer US
Erschienen in: Metabolic Brain Disease / Ausgabe 2/2013
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-013-9381-7

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

Chronic hyperammonemia, glutamatergic neurotransmission and neurological alterations

Hepatic encephalopathy: an enigma from patient to enzyme and back

In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using 1H Magnetic Resonance Spectroscopy

Efficacy of liver assisting in patients with hepatic encephalopathy with special focus on plasma exchange

Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy

Antibiotics for the treatment of hepatic encephalopathy